Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing
Clinical trial NCT00647270 · COMPLETED
Trial details
- NCT number
- NCT00647270
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2009-04-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.